Research programme: Alzheimer's disease diagnostics - Avid Radiopharmaceuticals

Drug Profile

Research programme: Alzheimer's disease diagnostics - Avid Radiopharmaceuticals

Alternative Names: Tau tangle diagnostic program

Latest Information Update: 04 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Avid Radiopharmaceuticals; Siemens Medical Solutions
  • Developer Avid Radiopharmaceuticals
  • Class Imaging agents; Radiopharmaceutical diagnostics
  • Mechanism of Action Positron-emission tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Alzheimer's disease

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for preclinical development in Alzheimer's-disease(Diagnosis) in USA
  • 17 Apr 2013 Preclinical development is ongoing the USA
  • 23 Mar 2010 Discontinued - Preclinical for Alzheimer's disease in USA (unspecified route) (Bayer/Avid collaboration)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top